Document
Academic Article
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Generically Dependent Continuant
Article
RDF description of Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects - http://irises.unilink.it/resource/item/49063
Information Content Entity